Vonaday (Lamivudine/Tenofovir/Efavirenz)
| Active Ingredient | Lamivudine/Tenofovir/Efavirenz |
|---|---|
| Indication: | HIV infection |
| Manufacturer: | Emcure Pharmaceuticals Ltd. |
| Packaging | 30 Tablets in bottle |
| Strength | 1200mg |
| Delivery Time | 6 To 15 days |
Vonaday is a fixed-dose, once-daily antiretroviral combination tablet containing three active ingredients: Lamivudine, Tenofovir disoproxil fumarate, and Efavirenz. It is used for the treatment of HIV-1 infection in adults and adolescents as part of Highly Active Antiretroviral Therapy (HAART).
Lamivudine and Tenofovir are nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs/NtRTIs), which block HIV replication by interfering with the virus’s genetic material.
Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that also inhibits the virus from multiplying.
Together, they help reduce viral load, increase CD4+ T-cell counts, and prevent the progression of HIV-related disease.








There are no reviews yet.